STAT

Opinion: Tech and health care need their own ‘Hippocratic oath’ to make digital health work

Companies working at the intersection of tech and health care need to change their ways before regulatory barriers and other problems set digital health back for years.

When a whistleblower revealed the details of Project Nightingale, a collaboration between Google and the Ascension health system, he or she also surfaced critical flaws in the ways that health care and tech work together.

As part of the deal, Ascension, a nonprofit Catholic hospital system that operates in 21 states, gave Google access to millions of patient records, including names and birth dates. The goal of Project Nightingale was to build new tools that help doctors extract key information from patients’ medical records and deliver more targeted medical treatments. It would also make it possible for doctors to spend more time with patients and less time combing through endless layers of electronic health data.

The problem was that the hospital system gave Google access to this mountain of data without the knowledge of doctors or patients. questioning compliance with privacy laws and whether Google had plans to monetize the data it received. Lawmakers similar concerns.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Plans For Generic Wegovy, Cough Syrup Warnings, And More
Biocon is developing a generic version of Novo Nordisk's Wegovy and is prepared to conduct a clinical trial next year if needed.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.

Related Books & Audiobooks